2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology

2014 Annual Meeting of the American Academy of Allergy, Asthma & Immunology | AAAAI 2014

The 2014 AAAAI Annual Meeting will feature "hundreds of educational offerings on a variety of topics including: allergic disease; asthma; immunotherapy; food allergy and GI disease; skin disease; PIDD; practice management; new technologies; and health care reform."

Conference Coverages

American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 4 in San Diego and attracted more than 5,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in allergic and immunologic disease. The conference highlighted recent advances in allergy, asthma, and immunology.
Long-Term and High-Dose Glucocorticosteroids for the Treatment of Chronic Rhinosinusitis
Glucocorticosteroids have been shown to be effective for treating chronic rhinosinusitis associated with allergic rhinitis and nasal polyps. There are several formulations of topical and oral agents available to clinicians.
Asthma vs. COPD: Does the Diagnosis Matter in the Clinic When Designing a Management Plan?
Do asthma and COPD share enough characteristics such as reduced rate of airflow resulting from increased inflammation, along with similar responses to some forms of treatment, reduce the importance of differential diagnosis?
Personalized Medicine and the Role of Biologics in Severe Chronic Rhinosinusitis
Research into the pathogenesis of chronic rhinosinusitis has shed new light on the association between asthma and CRS while also providing new insight into CRS disease endotypes, enabling clinicians to individualize treatment regimens.
Texting Medication Reminders Improves Asthma Control in Adolescents
A pilot program that uses text message medication reminders has led to reduced asthma exacerbations and fewer hospitalizations among participating inner-city adolescents.
Research Points to Potential Novel Treatments for Severe Asthma
Although the mechanisms of disease severity for this form of asthma are not fully understood, progress has been made in identifying promising targets for new treatments.
Nanotechnology Applications in Immunology and Allergy
Successful applications of nanotechnology in the field of immunology will enable new generations of vaccines, adjuvants, and immunomodulatory drugs that aim to improve clinical outcomes in response in a range of infectious and non-infectious diseases.
Chronic Urticaria Remains a Challenging Condition to Assess and Treat
Due to its ambiguous etiology, the low cost-to-benefit ratio associated with many laboratory tests used in assessment and diagnosis, and the low-to-moderate strength of evidence supporting many pharmacologic approaches to treatment, chronic urticaria can be one of the most difficult inflammatory skin conditions for clinicians to manage.
The Evidence-based Management of Chronic Urticaria
A review of the various guidelines on the treatment of chronic urticaria shows there is limited evidence demonstrating the efficacy of many commonly used medications, with the strongest evidence supporting the use of one or more second-generation antihistamines.

Most Popular


$vacMongoViewPlus$ $vAR$